![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1813233
¼¼°èÀÇ Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ ½ÃÀå ¿¹Ãø(-2032³â) : Á¦Ç° À¯Çü, À¯Åë ä³Î, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ºÐ¼®Precision Beard Genomics Market Forecasts to 2032 - Global Analysis By Product Type, Distribution Channel, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ ½ÃÀåÀº 2025³â¿¡ 5,413¸¸ ´Þ·¯¸¦ Â÷ÁöÇϰí, 2032³â¿¡´Â 1¾ï 5,768¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 16.5%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Á¤¹Ð ¼ö¿° À¯ÀüüÇÐÀº À¯ÀüÀÚ Á¶»ç¿Í ±×·ç¹ÖÀÇ Çõ½ÅÀ» ÅëÇÕÇÏ¿© DNA°¡ ¼ö¿°ÀÇ ¼ö¿°ÀÇ ±½±â, µÎ²², Áú°¨ µî ¼ö¿°ÀÇ Æ¯Â¡¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´ÂÁö ÇØµ¶Çϴ ȹ±âÀûÀÎ Á¢±Ù¹ýÀÔ´Ï´Ù. ƯÁ¤ DNA ¿°±â¼¿À» ºÐ¼®ÇÔÀ¸·Î½á Àü¹®°¡µéÀº ±× »ç¶÷ÀÌ ¼ö¿°À» £°Ô ±â¸£±â ½¬¿îÁö, ¹ÝÁ¡¿¡ ½Ã´Þ¸®´ÂÁö, ¾Æ´Ï¸é ºÎµå·¯¿î ¼ö¿°À» À¯ÁöÇÏ´ÂÁö¸¦ ÃßÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Áö½ÄÀº Ç¥Àû ¿ÀÀÏ, Ư¼ö Æ®¸®Æ®¸ÕÆ®, ¼ºÀå ÃËÁøÁ¦ µî °³Àκ° ¸ÂÃã ¼ö¿° °ü¸® ¿ä¹ýÀ» ¸¸µå´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ¾ó±¼ ÅÐÀÇ ¹ß´Þ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â È£¸£¸ó ¼öÁØ, ¸ð³¶ ±â´É, ¿µ¾ç ´ë»çÀÇ ¿¬°ü¼ºµµ ¹àÇôÁ³½À´Ï´Ù. ÀÌ ¹æ¹ýÀ» ÅëÇØ °³ÀÎÀº ´õ °Ç°ÇÏ°í ´õ °³ÀÎÀûÀÎ ¼ö¿° °á°ú¸¦ ¾ò±â À§ÇØ °úÇп¡ ±â¹ÝÇÑ Àü·«À» äÅà ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, ¾à 10,000°³ÀÇ ´ÜÀÏ À¯ÀüÀÚ ÁúȯÀÌ Àü ¼¼°è Àα¸ÀÇ ¾à 1%¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ´Â Á¤¹Ð À¯Àüü °Ë»ç°¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â À¯ÀüÀû ÇüÁú°ú º´Å°¡ ¸Å¿ì ±¤¹üÀ§ÇÏ´Ù´Â °ÍÀ» º¸¿©ÁÝ´Ï´Ù. ¿©±â¿¡´Â ƯÁ¤ À¯ÀüÀÚ ¸¶Ä¿ÀÇ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ´Â ¼ö¿° ¼ºÀå, ¼ö¿° ¹Ðµµ, È£¸£¸ó ¹Î°¨¼º µî Æ´»õ ½ÃÀåµµ Æ÷ÇԵ˴ϴÙ.
¼ºÀåÇÏ´Â ³²¼º ±×·ç¹Ö »ê¾÷
ȣȲÀ» ´©¸®°í ÀÖ´Â ³²¼º¿ë ±×·ç¹Ö »ê¾÷Àº Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ ½ÃÀåÀÇ È®´ë¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. °ú°Å ¿©¼º¿ë Á¦Ç°ÀÌ ÁÖ·ù¸¦ ÀÌ·ç¾ú´ø ÀÌ »ê¾÷Àº ƯÈ÷ ¼ö¿° ¹®È°¡ ¼¼°èÀûÀ¸·Î Àα⸦ ²ø¸é¼ ³²¼ºµéÀÇ Âü¿©°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. À¯¸íÀÎ, ¼Ò¼È ¹Ìµð¾î, ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È¿¡ ¿µÇâÀ» ¹Þ¾Æ ³²¼ºµéÀº ÇöÀç °íµµÀÇ ±×·ç¹Ö ·çƾ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¸¹Àº »ç¶÷µéÀÌ ¼ö¿°ÀÇ ½ºÅ¸ÀÏÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó °í¸£Áö ¾ÊÀº ¼ºÀå°ú ¾ãÀº ¹Ðµµ µîÀÇ ¹®Á¦¸¦ ÇØ°áÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» ã°í ÀÖ½À´Ï´Ù. Á¤¹Ð¼ö¿°À¯Àüü´Â ÀÌ·¯ÇÑ ¿ä±¸¿¡ ºÎÀÀÇÏ¿© È¿°úÀûÀÎ °á°ú¸¦ µµÃâÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÈ DNA ±â¹Ý ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒºñÀÚ ÇൿÀÇ º¯È´Â Çõ½Å¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ¸ç °³ÀÎÈµÈ ±×·ç¹ÖÀÇ ±âȸ¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù.
À¯Àüü °Ë»çÀÇ ³ôÀº ºñ¿ë
Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ ½ÃÀåÀ» Á¦ÇÑÇÏ´Â °¡Àå Å« ¹®Á¦´Â DNA °Ë»ç¿¡ ¸¹Àº ºñ¿ëÀÌ µç´Ù´Â Á¡ÀÔ´Ï´Ù. ±â¼úÀÇ ¹ßÀü¿¡µµ ºÒ±¸ÇÏ°í °í±Þ À¯ÀüÀÚ ¿°±â¼¿ ºÐ¼®¿¡´Â °í°¡ÀÇ Àåºñ, ¼÷·ÃµÈ Àü¹®°¡, °í±Þ ºÐ¼® µµ±¸°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ëÀº Á¦Ç° °¡°Ý »ó½ÂÀ¸·Î À̾îÁ® ¿¹»ê¿¡ ¹Î°¨ÇÑ ¼ÒºñÀÚÀÇ Á¢±ÙÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ¸ÂÃãÇü ¼ö¿° À¯Àüü ½ÃÀåÀº ºÎÀ¯Ãþ¿¡ ÁýÁߵǾî ÀÖÀ¸¸ç, ÁÖ·ù·ÎÀÇ º¸±ÞÀº ¹ÌÁøÇÕ´Ï´Ù. °Ë»ç ºñ¿ë°ú Á¦Ç° ºñ¿ëÀÇ ´ëÆøÀûÀÎ Àý°¨ ¾øÀÌ´Â ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ º¸±ÞÀº Á¦ÇÑÀûÀÏ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù. µû¶ó¼ °¡°Ý ¹®Á¦¸¦ ÇØ°áÇÏ´Â °ÍÀº º¸´Ù ±¤¹üÀ§ÇÑ ½ÃÀå ħÅõ¸¦ ´Þ¼ºÇϰí Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ »ê¾÷ÀÇ Áö¼Ó°¡´ÉÇÑ ¼ºÀåÀ» ÃËÁøÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.
÷´Ü ±â¼ú°úÀÇ À¶ÇÕ
À¯ÀüüÇаú ÷´Ü ±â¼úÀÇ À¶ÇÕÀº Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ ½ÃÀå¿¡ Å« ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀΰøÁö´É°ú ¸Ó½Å·¯´×Àº À¯ÀüÀÚ µ¥ÀÌÅͼ¼Æ®¸¦ ó¸®ÇÏ¿© ³ôÀº Á¤È®µµ·Î ÁøÈÇÏ´Â ±×·ç¹Ö ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇâÈÄ ¿þ¾î·¯ºí ±â±â¿ÍÀÇ ÅëÇÕÀ» ÅëÇØ ¼ÒºñÀÚ´Â ¼ö¿°ÀÇ °Ç° ÁöÇ¥¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ°í °³ÀÎÈµÈ Á¶¾ðÀ» ¹ÞÀ» ¼ö ÀÖ°Ô µÉ ¼öµµ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº °í°´ °æÇèÀ» º¸´Ù ÀÎÅÍ·¢Æ¼ºêÇÏ°í µ¥ÀÌÅÍ Áß½ÉÀûÀ¸·Î ¸¸µé¾î °í°´ Ãæ¼ºµµ¸¦ °ÈÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, À¯ÀüüÇÐ Á¦°ø¾÷ü¿Í ±â¼ú ±â¾÷°úÀÇ Á¦ÈÞ´Â »õ·Î¿î ºñÁî´Ï½º ¸ðµ¨À» âÃâÇϰí, ¼¼°è ÁøÃâ ¹üÀ§¸¦ È®´ëÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ÀüȯÀÌ ÁøÇàµÇ´Â °¡¿îµ¥, ±â¼úÀ» Ȱ¿ëÇÑ °³ÀÎÈ´Â ±×·ç¹ÖÀÇ °³³äÀ» ÀçÁ¤ÀÇÇϰí Àü ¼¼°èÀûÀ¸·Î ½ÃÀå µµÀÔÀ» °¡¼ÓÈÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.
¼ÒºñÀÚÀÇ È¸ÀÇ¿Í ¹®ÈÀû ÀúÇ×
¼ÒºñÀÚÀÇ ¸Á¼³ÀÓ°ú ¹®ÈÀû ÀúÇ×Àº Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ ½ÃÀå¿¡ Áö¼ÓÀûÀÎ À§ÇùÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¸¹Àº ÀáÀçÀû »ç¿ëÀÚµéÀº DNA ±â¹Ý ¼Ö·ç¼Ç¿¡ ´ëÇÑ ºÒ½Å, ÇÁ¶óÀ̹ö½Ã Ä§ÇØ¿¡ ´ëÇÑ µÎ·Á¿ò, Á¦Ç° °á°ú¿¡ ´ëÇÑ ÀDZ¸½É, °úÇÐÀÌ °³ÀÎÀÇ ¿Ü¸ð¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ºÒ¾È°¨À» °¡Áö°í ÀÖ½À´Ï´Ù. ÀϺΠÁö¿ª¿¡¼´Â À¯ÀüÀÚ °Ë»ç°¡ »çȸÀûÀ¸·Î³ª À±¸®ÀûÀ¸·Î ¹Î°¨ÇÑ °ÍÀ¸·Î °£ÁÖµÇ¾î ¼ö¿ëÀÌ ´õ¿í Á¦ÇѵǾî ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϺΠÁö¿ª¿¡¼´Â ¼ö¿°À» ±â¸£´Â °ÍÀÌ ´Ü¼øÇÑ ¹ÌÀû ½À°üÀ¸·Î °£ÁֵǾî ÷´Ü À¯Àüü ¼Ö·ç¼ÇÀÌ ºÒÇÊ¿äÇϰųª ºñ½Î°Ô ´À²¸Áö±âµµ ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀúÇ×Àº ƯÈ÷ °³ÀÎÈµÈ ÇコÄɾî¿Í ±×·ç¹Ö Çõ½ÅÀ» Á¢ÇÒ ±âȸ°¡ ÀûÀº ½ÃÀå¿¡¼ äÅ÷üÀ» ¶³¾î¶ß¸®°í ÀÖ½À´Ï´Ù. ÀνÄ, ±³À°, ½Å·Ú ±¸ÃàÀ» ÅëÇØ ȸÀǷп¡ ´ëóÇÏ´Â °ÍÀÌ ÁÖ·ù¿¡ ¹Þ¾Æµé¿©Áö°í Àå±âÀûÀÎ ¼ºÀåÀ» ÀÌ·ç±â À§ÇØ ÇʼöÀûÀÔ´Ï´Ù.
COVID-19´Â Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ »ê¾÷¿¡ µµÀü°ú ±âȸ¸¦ µ¿½Ã¿¡ °¡Á®¿Ô½À´Ï´Ù. Ãʱ⿡´Â Àü ¼¼°èÀûÀÎ ±ÔÁ¦·Î ÀÎÇØ °ø±Þ¸ÁÀÌ È¥¶õ½º·¯¿ü°í, Å×½ºÆ® ¾÷¹«°¡ Áö¿¬µÇ¾î ¸ÂÃãÇü ±×·ç¹Ö Á¦Ç°À» ±¸ÇÒ ¼ö ¾ø¾ú½À´Ï´Ù. ¼ÒºñÀÚÀÇ ¿ì¼±¼øÀ§°¡ »ýÇÊǰÀ¸·Î ¿Å°Ü°¡¸é¼ ÀϽÃÀûÀ¸·Î ±×·ç¹Ö ÁöÃâÀÌ °¨¼ÒÇß½À´Ï´Ù. ÇÑÆí, COVID-19´Â Àڱ⠰ü¸® ÀǽÄ, ¿Â¶óÀÎ ¼îÇÎ ½À°ü, À£ºù¿¡ ÃÊÁ¡À» ¸ÂÃá ¶óÀÌÇÁ½ºÅ¸ÀÏÀ» ÃËÁøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È´Â µðÁöÅÐ Ç÷§ÆûÀ» ÅëÇØ DNA ±â¹Ý ¼ö¿° ŰƮ¸¦ Á¦°øÇÏ´Â ±â¾÷¿¡°Ô ÀÌÀÍÀ» °¡Á®´ÙÁÖ¾ú½À´Ï´Ù. ¿ø°Ý ±Ù¹« ¹®È´Â ³²¼ºµéÀÌ ¼ö¿°À» ±â¸£°Å³ª ±×·ç¹ÖÀ» ½ÃµµÇÏ´Â °ÍÀ» ´õ¿í ºÎÃß°å½À´Ï´Ù. ½ÃÀåÀº ´Ü±âÀûÀÎ ÈÄÅ𸦠°æÇèÇßÁö¸¸,ÀÌ À§±â´Â °á±¹ °³ÀÎÈµÈ ¼ö¿° À¯ÀüüÇÐÀÇ Àå±âÀûÀÎ ¼ö¿ëÀ» °¡¼ÓÈÇß½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È À¯ÀüÀÚ °Ë»ç ŰƮ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀåÀ» Çü¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
À¯ÀüÀÚ °Ë»ç ŰƮ ºÎ¹®Àº ´Ù¸¥ ¸ðµç ºÎ¹®ÀÇ ±â¹Ý ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Å°Æ®´Â ¼ö¿°ÀÇ ±½±â, ¸ð³¶ÀÇ È°µ¿, Áú°¨ÀÇ º¯È µî ¼ö¿°ÀÇ Æ¯Â¡À» Æò°¡ÇÏ´Â µ¥ ÇÊ¿äÇÑ DNA Á¤º¸¸¦ »ý¼ºÇÕ´Ï´Ù. ÇüÁú ºÐ¼® Ç÷§Æû ¹× ¸ÂÃãÇü ¼ö¿° Á¦Ç° µî ÈÄ¼Ó ¼ºñ½º´Â °Ë»ç ŰƮ¿¡¼ ¼öÁýÇÑ µ¥ÀÌÅÍ¿¡ ÀüÀûÀ¸·Î ÀÇÁ¸Çϰí ÀÖ½À´Ï´Ù. Àú·ÅÇÑ °¡°ÝÀÇ °¡Á¤¿ë °Ë»ç ŰƮÀÇ µîÀå°ú À¯ÀüÀÚ °³ÀÎÈ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ È£±â½ÉÀÌ È®»ê¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. °úÇÐÀûÀ¸·Î ÀÔÁõµÈ ±×·ç¹Ö ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó, °Ë»ç ŰƮ´Â ÇʼöÀûÀÎ Á¸Àç·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. °³ÀÎÈ ÇÁ·Î¼¼½º¸¦ ½ÃÀÛÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â °Ë»ç ŰƮ´Â ½ÃÀåÀÇ Áö¹èÀû ÁöÀ§¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù.
ÇÏÀÌÅ×Å© ½ºÅ¸Æ®¾÷ ¹× ¾Û °³¹ßÀÚ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ±â¼ú ½ºÅ¸Æ®¾÷ ¹× ¾Û °³¹ßÀÚ ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À̵éÀº ¸ð¹ÙÀÏ ±â¹Ý µµ±¸, AI ±â¹Ý ´ë½Ãº¸µå, DNA °Ë»ç¿Í ¸ÂÃãÇü ¼ö¿° °ü¸®¸¦ ¿øÈ°ÇÏ°Ô ¿¬°áÇØÁÖ´Â ´ëÈÇü Áø´Ü ¾ÛÀ» Á¦°øÇÔÀ¸·Î½á Çõ½ÅÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À¯¿¬¼ºÀ» ÅëÇØ ½ÃÀåÀÇ ¿ä±¸¿¡ ºü¸£°Ô ÀûÀÀÇϰí, »õ·Î¿î ±â¼úÀ» ÅëÇÕÇϰí, ½ÇÇè½Ç ¹× ±×·ç¹Ö ȸ»ç¿Í Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¸ÎÀ» ¼ö ÀÖ½À´Ï´Ù. ¼ÒºñÀÚµéÀÌ Á¡Á¡ ´õ µðÁöÅÐ ¼Ö·ç¼Ç°ú °³ÀÎÈµÈ °æÇèÀ» ¼±È£ÇÔ¿¡ µû¶ó, ÀÌ ºÎ¹®Àº ºü¸£°Ô ¼ºÀåÇÒ ¼ö ÀÖ´Â À¯¸®ÇÑ À§Ä¡¿¡ ÀÖ½À´Ï´Ù. À¯ÀüüÇаú ±â¼úÀÇ À¶ÇÕÀ» ÅëÇØ ½ºÅ¸Æ®¾÷Àº °¡Àå ³ôÀº ¼ºÀå·üÀ» ´Þ¼ºÇϰí, ½ÃÀåÀÇ Àü¸ÁÀ» ¹Ù²Ü °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â °·ÂÇÑ À¯Àüü ¿¬±¸ »ýŰè¿Í °³ÀÎÈµÈ ±×·ç¹Ö¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÁغñµÈ ŵµ·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ëÇü »ý¸í°øÇÐ ±â¾÷, ±â¼ú ±â¹Ý ½ºÅ¸Æ®¾÷, ÈÀåǰ ºê·£µå¿ÍÀÇ Á¦ÈÞ°¡ ÀÌ ºÐ¾ßÀÇ Çõ½ÅÀ» °¡¼ÓÈÇϰí ÀÖ½À´Ï´Ù. ³²¼ºµéÀÇ Àڱ⠰ü¸®¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ³ôÀº ±¸¸Å·ÂÀÌ DNA ±â¹Ý ¼ö¿° ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·ç¹Ö Æ®·»µå´Â ¿©ÀüÈ÷ ÀþÀº Ãþ¿¡°Ô Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖÀ¸¸ç, ÷´Ü Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾çÈ£ÇÑ ±ÔÁ¦¿Í ¼º¼÷ÇÑ E-Commerce ³×Æ®¿öÅ©°¡ Áö¼ÓÀûÀÎ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¶°ÇµéÀÌ °áÇÕµÇ¾î ¼¼°è Á¤¹Ð ¼ö¿° À¯ÀüüÇÐ ½ÃÀå¿¡¼ ºÏ¹ÌÀÇ ¿ìÀ§´Â È®°íÇÕ´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µµ½Ã °ÅÁÖÀÚÀÇ Áõ°¡, °¡Ã³ºÐ ¼ÒµæÀÇ Áõ°¡, ¸ö´ÜÀå¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ Áß±¹, Àεµ, Çѱ¹, ÀϺ» µîÀÇ ±¹°¡¿¡¼ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ³²¼ºÀÇ ¸ö´ÜÀå ¹®È´Â ±¹Á¦ÀûÀÎ ÆÐ¼Ç Æ®·»µå, ¼Ò¼È ¹Ìµð¾î, À¯¸íÀÎÀÇ Ãßõ¿¡ ÀÇÇØ Çü¼ºµÇ°í, ±× ±â¼¼¸¦ ´õÇØ°¡°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ÀþÀº ÃþÀº À¯Àüü °Ë»ç ŰƮ, ¸ÂÃãÇü ¼ö¿° °ü¸® µî ÷´Ü ±×·ç¹Ö ±â¼úÀ» Àû±Ø ÁöÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌÄ¿¸Ó½ºÀÇ È°¹ßÇÑ ¼ºÀå°ú ½º¸¶Æ®ÆùÀÇ º¸±Þµµ ¼ºÀå¿¡ ÈûÀ» º¸Å°í ÀÖ½À´Ï´Ù. ¹æ´ëÇÑ ¼ÒºñÀÚ ±â¹ÝÀ» °¡Áø ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÌ ½ÃÀå¿¡¼ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÌ´Â Áö¿ªÀÔ´Ï´Ù.
According to Stratistics MRC, the Global Precision Beard Genomics Market is accounted for $54.13 million in 2025 and is expected to reach $157.68 million by 2032 growing at a CAGR of 16.5% during the forecast period. Precision Beard Genomics represents a breakthrough approach that integrates genetic research with grooming innovation to decode how a person's DNA impacts beard traits such as fullness, thickness, and texture. By analyzing particular DNA sequences, experts can estimate whether someone is more likely to grow a dense beard, struggle with patchiness, or maintain softer strands. This knowledge supports the creation of individualized beard-care regimens, including targeted oils, specialized treatments, and growth enhancers. In addition, it uncovers links between hormone levels, follicle function, and nutrient metabolism that influence facial hair development. Through this method, individuals can adopt science-based strategies for achieving healthier, more personalized beard outcomes.
According to the World Health Organization (WHO), An estimated 10,000 single-gene disorders affect approximately 1% of the global population. This highlights the vast landscape of heritable traits and conditions that precision genomic testing can address-including niche applications like beard growth, density, and hormonal sensitivity, which may be influenced by specific genetic markers.
Growing male grooming industry
The booming male grooming sector significantly contributes to the rise of the Precision Beard Genomics market. Once dominated by women's products, the industry has witnessed a surge in male participation, especially with the global popularity of beard culture. Influenced by celebrities, social media, and lifestyle changes, men are now more invested in advanced grooming routines. Many seek solutions that not only enhance beard style but also address challenges like uneven growth and thin density. Precision Beard Genomics caters to these needs by offering DNA-based solutions designed for effective results. This shift in consumer behavior is fueling innovation and expanding opportunities in personalized grooming.
High cost of genomic testing
A major challenge limiting the Precision Beard Genomics market is the considerable expense of DNA testing. Despite improvements in technology, advanced genetic sequencing continues to demand costly equipment, trained experts, and high-end analytical tools. These expenses translate into higher product prices, restricting accessibility for budget-conscious consumers. Consequently, the market for personalized beard genomics is largely concentrated within affluent segments, leaving mainstream adoption underdeveloped. Without significant reductions in testing and product costs, the reach of these solutions will remain constrained. Addressing affordability issues is therefore essential to achieving broader market penetration and driving sustainable growth in the Precision Beard Genomics industry.
Integration with advanced technologies
Merging genomics with cutting-edge technologies offers significant opportunities for the Precision Beard Genomics market. Artificial intelligence and machine learning can process genetic datasets to deliver highly accurate and evolving grooming solutions. Future integration with wearable devices may allow consumers to monitor beard health indicators in real time and receive personalized advice. These innovations strengthen customer loyalty by making the experience more interactive and data-driven. Moreover, partnerships between genomics providers and technology firms could generate fresh business models and enhance global reach. With the ongoing digital transformation, technology-enabled personalization has the potential to redefine grooming practices and accelerate market adoption worldwide.
Consumer skepticism and cultural resistance
Consumer hesitation and cultural opposition represent ongoing threats to the Precision Beard Genomics market. Many potential users distrust DNA-based solutions, fearing privacy breaches, questioning product results, or feeling uneasy about science influencing personal grooming. In some regions, genetic testing is considered socially or ethically sensitive, further limiting acceptance. For others, beard care is seen as a simple aesthetic routine, making advanced genomic solutions appear unnecessary or overpriced. This resistance weakens adoption rates, especially in markets with limited exposure to personalized healthcare or grooming innovations. Addressing skepticism through awareness, education, and trust-building will be critical for achieving mainstream acceptance and long-term growth.
COVID-19 created both challenges and opportunities for the Precision Beard Genomics industry. In the early phase, global restrictions disrupted supply chains, delayed testing operations, and hindered the availability of personalized grooming products. Consumer priorities also shifted toward essentials, leading to temporary declines in grooming expenditures. On the other hand, the pandemic boosted self-care awareness, online shopping habits, and wellness-focused lifestyles. This shift benefited companies offering DNA-based beard kits through digital platforms. The remote work culture further encouraged men to experiment with beard growth and grooming. Although the market experienced short-term setbacks, the crisis ultimately accelerated long-term acceptance of personalized beard genomics.
The genetic testing kits segment is expected to be the largest during the forecast period
The genetic testing kits segment is expected to account for the largest market share during the forecast period since they act as the foundation for all other segments. These kits generate the DNA information required to assess beard characteristics, including thickness, follicle activity, and texture variations. Subsequent services, such as trait analysis platforms and customized beard products, rely entirely on the data collected from testing kits. The rise of affordable at-home testing and consumer curiosity about genetic personalization has fueled widespread adoption. As demand for science-backed grooming solutions grows, testing kits remain indispensable. Their critical role in initiating the personalization process ensures they maintain the dominant market position.
The tech startups & app developers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the tech startups & app developers segment is predicted to witness the highest growth rate. These companies are spearheading innovation by offering mobile-based tools, AI-driven dashboards, and interactive consultation apps that seamlessly link DNA testing with customized beard care. Their flexibility allows them to quickly adapt to market needs, integrate emerging technologies, and form strategic partnerships with labs and grooming companies. With consumers increasingly favoring digital solutions and personalized experiences, this segment is well-positioned to expand rapidly. By blending genomics with technology, startups are set to deliver the highest growth rate and transform the market landscape.
During the forecast period, the North America region is expected to hold the largest market share owing to its strong genomic research ecosystem and consumer readiness for personalized grooming. The presence of major biotech companies, tech-driven startups, and partnerships with cosmetic brands has accelerated innovation in this field. High purchasing power, along with increasing focus on male self-care, encourages adoption of DNA-based beard solutions. Grooming trends remain highly influential among younger demographics, boosting demand for advanced products. Furthermore, favorable regulations and a mature e-commerce network support continued growth. Together, these conditions solidify North America's dominant position in the global Precision Beard Genomics market.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rising urban lifestyles, higher disposable incomes, and increased awareness of personal grooming are fueling demand across countries such as China, India, South Korea, and Japan. Male grooming culture is gaining momentum, shaped by international fashion trends, social media, and celebrity endorsements. The region's younger demographic is highly receptive to advanced grooming technologies, including genomic testing kits and customized beard care. Growth is further supported by strong e-commerce expansion and widespread smartphone usage. With its vast consumer base, Asia-Pacific represents the region with the highest growth rate in this market.
Key players in the market
Some of the key players in Precision Beard Genomics Market include 23andMe, AncestryDNA, Helix, Gene by Gene, Ltd., Color Genomics, Veritas Genetics, DNAfit, Toolbox Genomics, Orig3n, Everlywell, Nebula Genomics, Caligenix, Genoplan, Xcode Life and Mapmygenome.
In June 2025, 23andMe Holding Co. announced that it has entered into a definitive agreement with TTAM Research Institute ("TTAM"), a nonprofit public benefit corporation based in California and led by 23andMe Co-Founder and former CEO Anne Wojcicki, for the sale of substantially all of the Company's assets, including the Personal Genome Service (PGS) and Research Services business lines and the Lemonaid Health business, for a purchase price of $305 million.
In May 2025, Mapmygenome has acquired Canadian microbial sequencing player Microbiome Insights. The acquisition includes the CAP-accredited Canadian laboratory of Microbiome Insights as well as its intellectual property. While post-acquisition Microbiome Insights will maintain its role as a premier CRO, Mapmygenome said it will roll out its integrated genomics and microbiome testing services to North America to make holistic, data-driven health solutions more accessible.
In August 2022, Gene by Gene and Verogen, Inc. announced a partnership to accelerate the adoption of forensic investigative genetic genealogy. As part of the agreement, Gene by Gene, parent company of FamilyTreeDNA, will support DNA uploads generated from the Verogen ForenSeq Kintelligence kit, the only ANAB accredited technology approved for forensic investigative genetic genealogy (FIGG).